Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours

被引：0
|
作者：
Faidon-Marios Laskaratos
Martin Walker
Keval Naik
Emmanouil Maragkoudakis
Nikolaos Oikonomopoulos
Lee Grant
Tim Meyer
Martyn Caplin
Christos Toumpanakis
机构：
[1] Centre for Gastroenterology,Department of Infectious Disease Epidemiology
[2] Neuroendocrine Tumour Unit,Department of Radiology
[3] Centre for Gastroenterology,undefined
[4] Royal Free Hospital NHS Foundation Trust,undefined
[5] School of Public Health,undefined
[6] Faculty of Medicine,undefined
[7] Imperial College London,undefined
[8] Royal Free Hospital NHS Foundation Trust,undefined
[9] UCL Cancer Institute,undefined
[10] University College London,undefined
来源：
British Journal of Cancer | 2016年 / 115卷
关键词：
octreotide LAR; neuroendocrine tumours; antiproliferative activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1321 / 1327
页数：6
相关论文
共 50 条
  • [1] Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours
    Laskaratos, Faidon-Marios
    Walker, Martin
    Naik, Keval
    Maragkoudakis, Emmanouil
    Oikonomopoulos, Nikolaos
    Grant, Lee
    Meyer, Tim
    Caplin, Martyn
    Toumpanakis, Christos
    BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1321 - 1327
  • [2] Predictive Factors for Antiproliferative Activity of Octreotide LAR in Advanced Neuroendocrine Tumors
    Toumpanakis, C.
    Laskaratos, F.
    Maragkoudakis, E.
    Naik, K.
    Oikonomopoulos, N.
    Walker, M.
    Grant, L.
    Meyer, T.
    Caplin, M.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 126 - 126
  • [3] Antiproliferative activity of octreotide LAR in advanced neuroendocrine tumors.
    Toumpanakis, Christos
    Laskaratos, Faidon
    Maragkoudakis, Emmanouil
    Naik, Keval
    Oikonomopoulos, Nikolaos
    Walker, Martin
    Grant, Lee
    Meyer, Tim
    Caplin, Martyn E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] PREDICTORS OF ANTIPROLIFERATIVE EFFECT OF LANREOTIDE AUTOGEL AS FIRST-LINE THERAPY FOR ADVANCED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOURS (GEP NET)
    Laskaratos, Faidon-Marios
    Megapanou, Maria
    Papantoniou, Dimitrios
    Hayes, Aimee R.
    von Stempel, Conrad
    Phillips, Edward
    Furnace, Myles
    Kousteni, Margarita
    Shah, Heer
    Mandair, Dalvinder
    Caplin, Martyn
    Toumpanakis, Christos
    GASTROENTEROLOGY, 2018, 154 (06) : S197 - S197
  • [5] Predictors of Antiproliferative Effect of Lanreotide Autogel (LA) as First-Line Therapy for Advanced Neuroendocrine Tumors (NETs)
    Laskaratos, F.
    Megapanou, M.
    Papantoniou, D.
    Hayes, A.
    Von Stempel, C.
    Phillips, E.
    Furnace, M.
    Kousteni, M.
    Shah, H.
    Mandair, D.
    Caplin, M.
    Toumpanakis, C.
    NEUROENDOCRINOLOGY, 2018, 106 : 201 - 201
  • [6] Beneficial effect of dose escalation of Octreotide-LAR as first-line therapy in patients with acromegaly
    Colao, Annamaria
    Pivonello, Rosario
    Auriemma, Renata S.
    Galdiero, Mariano
    Savastano, Silvia
    Lombardi, Gaetano
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 157 (05) : 579 - 587
  • [7] A Combination of RAD001 and Octreotide LAR as First-line Treatment of Well Differentiated Neuroendocrine Tumours - an ITMO (Italian Trials in Medical Oncology) Group Study
    Baietta, E.
    Catena, L.
    Biondani, P.
    Fazio, N.
    Giuffrida, D.
    Ricci, S.
    Aieta, M.
    Pucci, F.
    Bianco, N.
    Valente, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S480 - S480
  • [8] Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma
    Butturini, G.
    Bettini, R.
    Missiaglia, E.
    Mantovani, W.
    Dalai, I.
    Capelli, P.
    Ferdeghini, M.
    Pederzoli, P.
    Scarpa, A.
    Falconi, M.
    ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1213 - 1221
  • [9] Everolimus in combination with octreotide LAR as the first-line treatment for advanced neuroendocrine tumors: A phase II trial of the ITMO (Italian Trials in Medical Oncology) group
    Bajetta, Emilio
    Catena, Laura
    Fazio, Nicola
    Pusceddu, Sara
    Biondani, Pamela
    Blanco, Giusi
    Ricci, Sergio
    Aieta, Michele
    Pucci, Francesca
    Valente, Monica
    Bianco, Nadia
    Bellomo, Fernanda
    Mauri, Chiara
    Buonandi, Pasquale
    Roberto, Vincenza
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Review of Octreotide scans as a first-line investigation in patients with suspected neuroendocrine tumour
    McNally, O.
    Lynch, T.
    Mullan, C.
    Clarke, J.
    Hughes, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S308 - S309
12345